Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Apr 11, 2020
Emerging Company Profile
Clover: trimerizing fusion proteins
...Over $110 million Investors: Tianhe Life Sciences Venture Fund, Delos Capital, Lapam Capital, Betta Capital,
Sichuan Health Care Industry Fund
...
Read More
BioCentury
|
Dec 3, 2019
Financial News
Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron
...since 2016. Delos Capital and Lapam Capital led the round, with participation by Betta Capital,
Sichuan Health Care Industry Fund
...
Read More
Items per page:
10
1 - 2 of 2
BioCentury
|
Apr 11, 2020
Emerging Company Profile
Clover: trimerizing fusion proteins
...Over $110 million Investors: Tianhe Life Sciences Venture Fund, Delos Capital, Lapam Capital, Betta Capital,
Sichuan Health Care Industry Fund
...
Read More
BioCentury
|
Dec 3, 2019
Financial News
Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron
...since 2016. Delos Capital and Lapam Capital led the round, with participation by Betta Capital,
Sichuan Health Care Industry Fund
...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page